Strategic Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,668
Closed -$39.8K 203
2023
Q1
$39.8K Hold
11,668
0.01% 201
2022
Q4
$32.4K Sell
11,668
-2,000
-15% -$5.98K 0.01% 195
2022
Q3
$39K Hold
13,668
0.01% 194
2022
Q2
$47K Hold
13,668
0.01% 188
2022
Q1
$64K Hold
13,668
0.01% 195
2021
Q4
$82K Hold
13,668
0.01% 193
2021
Q3
$82K Hold
13,668
0.02% 182
2021
Q2
$170K Sell
13,668
-700
-5% -$7.58K 0.04% 163
2021
Q1
$147K Hold
14,368
0.04% 154
2020
Q4
$148K Buy
+14,368
New +$103K 0.04% 153

Other funds holding MDXG

Strategic Advisors's MDXG Position: Q2 2023 in Review

Strategic Advisors sold out of MiMedx Group (MDXG) in Q2 2023, closing a stake of 11,668 shares — an estimated $39.8K sold.

Strategic Advisors first reported a position in MDXG in Q4 2020 and held it in 10 quarters. The position peaked at $170K in Q2 2021. 177 funds tracked by Wall St. Rank hold MDXG as of Q2 2023.

  • Strategic Advisors reported no remaining MiMedx Group position as of Q2 2023 after selling out during the quarter.
  • Strategic Advisors sold 11,668 MiMedx Group shares in Q2 2023, an estimated $39.8K.
  • Strategic Advisors first reported a position in MiMedx Group in Q4 2020 and held it in 10 quarters.
  • Strategic Advisors's MiMedx Group position peaked at $170K in Q2 2021.
  • 177 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2023.

Based on Strategic Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.